92 research outputs found

    A Review of the Etiology Delirium

    Get PDF

    Serum fetuin-A and RANKL levels in patients with early stage breast cancer

    Get PDF
    Background: Breast cancer (BC) is the primary cause of mortality due to cancer in females around the world. Fetuin-A is known to increase metastases over signals and peroxisomes related with growing. Receptor activator of nuclear factor-kB ligand (RANKL) takes part in cell adhesion, and RANKL inhibition is used in the management of cancer. We aimed to examine the relationship between serum fetuin-A, RANKL levels, other laboratory parameters and clinical findings in women diagnosed with early stage BC, in our population. Methods: Women having early stage BC (n=117) met our study inclusion criteria as they had no any anti-cancer therapy before. Thirty-seven healthy women controls were also confirmed with breast examination and ultrasonography and/or mammography according to their ages. Serum samples were stored at -80 °C and analysed via ELISA. Results: Median age of the patients was 53 (range: 57-86) while it was 47 (range: 23-74) in the healthy group. Patients had lower high-density lipoprotein levels (p=0.002) and higher neutrophil counts (p=0.014). Fetuin-A and RANKL levels did not differ between the groups (p=0.116 and p=0.439, respectively) but RANKL leves were found to be lower in the favorable histological subtypes (p=0.04). Conclusions: In this study, we found no correlation between serum fetuin-A levels and clinical findings in patients diagnosed with early stage BC. However, RANKL levels are found to be lower in subgroups with favorable histopathologic subtypes such as tubular, papillary and mucinous BC and there was statistically significant difference

    Interventions for preventing oral mucositis for patients with cancer receiving treatment

    Get PDF
    Interventions for preventing oral mucositis for patients with cancer receiving treatmentTreatment for cancer (including bone marrow transplant) can cause oral mucositis (severe ulcers in the mouth). This painful condition can cause difficulties in eating, drinking and swallowing, and may also be associated with infections which may require the patient to stay longer in hospital. Different strategies are used to try and prevent this condition, and the review of trials found that some of these are effective. Two interventions, cryotherapy (ice chips) and keratinocyte growth factor (palifermin®) showed some benefit in preventing mucositis. Sucralfate is effective in reducing the severity of mucositis, and a further seven interventions, aloe vera, amifostine, intravenous glutamine, granulocyte‐colony stimulating factor (G‐CSF), honey, laser and antibiotic lozenges containing polymixin/tobramycin/amphotericin (PTA) showed weaker evidence of benefit. These were evaluated in patients with different types of cancer, undergoing different types of cancer treatment. Benefits may be restricted to the disease and treatment combinations evaluated

    Malign catatonia, treatment-resistant benzodiazepine but treated successfully With electroconvulsive treatment: A case report

    No full text
    Catatonia is a neuropsychiatric syndrome that can occur in schizophrenia, major depression and general medical condition. It presents with decrease in psychomotor activity or increase in motor symptoms or a change in motor activity in time. It is known that acute catatonia and malign catatonia responds to benzodiazepine treatment to a great extent. Here, we report a case of acute and malign catatonia which did not respond to benzodiazepine treatment and treated successfully with electroconvulsive treatment. As we know, there are many case reports and studies about catatonia in our country, but our case is the first case which is resistant to benzodiazepine treatment although it has an acute beginning, we think that our case has a clinical importance in this aspect

    Efficacy of aripiprazole augmentation in treatment resistant obsessive compulsive disorder: A preliminary report

    No full text
    Objective: To investigate efficacy of aripiprazole augmentation in treatment resistant obsessive compulsive disorder

    A study on the effects of quetiapine on social cognitive functions of schizophrenia patients

    No full text
    Objective: The objective of this study is to investigate the effects of quetiapine on social cognitive functions of schizophrenia patients
    corecore